Next Article in Journal
Interaction between DNA and Drugs Having Protonable Basic Groups: Characterization through Affinity Constants, Drug Release Kinetics, and Conformational Changes
Previous Article in Journal
Addendum: Šarić-Kundalić, B.; Fialová, S.; Dobeš, C.; Ölzant, S.; Tekeľová, D.; Grančai, D.; Reznicek, G.; Saukel, J. Multivariate Numerical Taxonomy of Mentha Species, Hybrids, Varieties and Cultivars. Sci. Pharm. 2009, 77, 851–876
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Budiarto, Bugi Ratno and Desriani. Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study. Sci. Pharm. 2016, 84, 103–111

Research Center for Biotechnology, Indonesian Institute of Sciences (LIPI), Jalan Raya Bogor Km. 46, Cibinong 16911, Indonesia
*
Authors to whom correspondence should be addressed.
Sci. Pharm. 2016, 84(4), 753; https://doi.org/10.3390/scipharm84040753
Submission received: 21 November 2016 / Revised: 1 December 2016 / Accepted: 21 November 2016 / Published: 2 December 2016
The authors wish to make the following corrections to their paper [1]:
The primer sequence that previously appeared on page 108 as 5’-CCAGCCCTCTGACGTCCAGCT-3’, should be 5’-CCAGCCCTCTGACGTCCAGCA-3’.
The drug name transtuzumab should have been written as trastuzumab.
The sentence that appears on page 106 as“adding mismatch site of SNP (A/G to T/G)”, should have been written as“adding mismatch site of SNP (A/G to G/A)”.
The authors would like to apologize for any inconvenience caused to the readers by these changes.The change does not affect the scientific results. The manuscript will be updated and the original will remain online on the article webpage.

Reference

  1. Budiarto, B.R.; Desriani. Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study. Sci. Pharm. 2016, 84, 103–111. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Budiarto, B.R.; Desriani. Correction: Budiarto, Bugi Ratno and Desriani. Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study. Sci. Pharm. 2016, 84, 103–111. Sci. Pharm. 2016, 84, 753. https://doi.org/10.3390/scipharm84040753

AMA Style

Budiarto BR, Desriani. Correction: Budiarto, Bugi Ratno and Desriani. Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study. Sci. Pharm. 2016, 84, 103–111. Scientia Pharmaceutica. 2016; 84(4):753. https://doi.org/10.3390/scipharm84040753

Chicago/Turabian Style

Budiarto, Bugi Ratno, and Desriani. 2016. "Correction: Budiarto, Bugi Ratno and Desriani. Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study. Sci. Pharm. 2016, 84, 103–111" Scientia Pharmaceutica 84, no. 4: 753. https://doi.org/10.3390/scipharm84040753

APA Style

Budiarto, B. R., & Desriani. (2016). Correction: Budiarto, Bugi Ratno and Desriani. Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study. Sci. Pharm. 2016, 84, 103–111. Scientia Pharmaceutica, 84(4), 753. https://doi.org/10.3390/scipharm84040753

Article Metrics

Back to TopTop